The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical presentation of immune-related colitis associated with PD-1 inhibitor monotherapy (MONO) and combination PD-1/CTLA-4 inhibitors (COMBO) in melanoma.
 
Daniel Ying Wang
No Relationships to Disclose
 
Dae Won Kim
No Relationships to Disclose
 
Neil J. Shah
No Relationships to Disclose
 
Robert Martin Conry
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis
 
Rutika Jitesh Mehta
No Relationships to Disclose
 
Ann W. Silk
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Prometheus (Inst)
 
Alice Zhou
No Relationships to Disclose
 
Amber L Voorhees
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Svetlana B McKee
No Relationships to Disclose
 
Jacqueline Norrell
No Relationships to Disclose
 
Janice M. Mehnert
Honoraria - EMD Serono; Genentech
Consulting or Advisory Role - Amgen; Merck Sharp & Dohme
Research Funding - Amgen (Inst); AstraZeneca (Inst); Immunocore (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - EMD Serono; Merck Sharp & Dohme
Other Relationship - Amgen; EMD Serono; Merck; Merck
 
Igor Puzanov
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - Amgen; Merck
 
Geoffrey Thomas Gibney
Consulting or Advisory Role - Novartis
Speakers' Bureau - Merck
 
Suthee Rapisuwon
Research Funding - Bristol-Myers Squibb
 
Zeynep Eroglu
No Relationships to Disclose
 
Douglas Buckner Johnson
Consulting or Advisory Role - Bristol-Myers Squibb; Genoptix
Research Funding - Incyte